UK-based start-up Beckley Psytech has completed an upsized Series B financing, raising €68m (US$80m). Proceeds...
Up To Date
Latest News
ERS Genomics and Cellular Engineering Technologies have entered into a CRISPR-Cas9 license agreement.
Setback for CureVac: Boehringer Ingelheim halts a 7-year-old €500m lung cancer collaboration with the...
Vaccine maker Valneva SE announced the initiation of a further Phase III trial for its COVID-19 vaccine...
Visus Therapeutics has baged a €20m stock financing to advance development of Brimochol for presbyopia
The protein eIF4A3 may hold the key for future cancer treatments, Karolinska researchers find.